SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹12 Cr | ₹13 Cr | ₹15 Cr | ₹11 Cr | ₹962,285 Cr |
What is the latest Consolidated Net Profit of SAKAR HEALTHCARE ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹12 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹962,285 Cr |
How is Consolidated Net Profit of SAKAR HEALTHCARE Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹12 Cr | -8.53 | |
| Mar2024 | ₹13 Cr | -15.95 | |
| Mar2023 | ₹15 Cr | 42.09 | |
| Mar2022 | ₹11 Cr | -100.00 | |
| Mar2021 | ₹962,285 Cr | - | |
Compare Consolidated Net Profit of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹896.2 Cr | 4.1% | -0.7% | 36.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 4.1% |
-0.7% |
36.2% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses